CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy

Journal of Clinical Gastroenterology

Volumn 41, Issue 4, 2007, Pages 375-379

  Bax, Dorine ^a   Siersema, Peter D ^a   Moons, Leon M G ^a   Dekken, Herman Van ^a   Tilanus, Hugo W ^a   Kusters, Johannes G ^a   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Barrett esophagus; CDX2; Intestinal differentiation

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 2; TRANSCRIPTION FACTOR CDX2;

COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STOMACH GLAND; STOMACH MUCOSA;

ANASTOMOSIS, SURGICAL; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; BIOPSY; ESOPHAGECTOMY; ESOPHAGUS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; METAPLASIA; MUCINS;

EID: 34147144230     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225520.36160.52     Document Type: Review

References (25)

1. Avidan B, Sonnenberg A, Schnell TG, et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002;97:1930-1936.
2. Falk GW. Barrett's esophagus. Gastroenterology. 2002;122:1569-1591.
3. Oberg S, Johansson J, Wenner J, et al. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg. 2002;235:338-345.
4. Eda A, Osawa H, Satoh K, et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol. 2003;38:14-22.
5. Guillem P, Billeret V, Buisine MP, et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer. 2000;88:856-861.
6. Flucke U, Steinborn E, Dries V, et al. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology. 2003;43:127-134.
7. Silberg DG, Swain GP, Suh ER, et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 2000;119:961-971.
8. Beck F, Erler T, Russell A, et al. Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extraembryonic membranes. Dev Dyn. 1995;204:219-227.
9. Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 2002;122:689-696.
10. Moons LM, Bax DA, Kuipers EJ, et al. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol. 2004;57:1063-1068.
11. Marchetti M, Caliot E, Pringault E. Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci. 2003;116:1429-1436.
12. O'Riordan JM, Tucker ON, Byrne PJ, et al. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy. Am J Gastroenterol. 2004;99:205-211.
13. Peitz U, Vieth M, Pross M, et al. Cardia-type metaplasia arising in the remnant esophagus after cardia resection. Gastrointest Endosc. 2004;59:810-817.
14. Dresner SM, Griffin SM, Wayman J, et al. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia. Br J Surg. 2003;90:1120-1128.
15. Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol. 1999;30:288-294.
16. Hamilton SR, Yardley JH. Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology. 1977;72:669-675.
17. Rindi G, Bishop AE, Daly MJ, et al. A mixed pattern of endocrine cells in metaplastic Barrett's oesophagus. Evidence that the epithelium derives from a pluripotential stem cell. Histochemistry. 1987;87:377-383.
18. Seery JP. Stem cells of the oesophageal epithelium. J Cell Sci. 2002;115:1783-1789.
19. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet. 2000;356:2079-2085.
20. Yamamoto H, Bai YQ, Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun. 2003;300:813-818.
21. Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol. 2004;17:1282-1288.
22. Glickman JN, Wang H, Das KM, et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol. 2001;25:87-94.
23. DeMeester SR, Wickramasinghe KS, Lord RV, et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol. 2002;97:2514-2523.
24. Lord RV, Wickramasinghe K, Johansson JJ, et al. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery. 2004;136:633-640.
25. Franchimont D, Covas A, Brasseur C, et al. Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy. 2003;35:850-853.